IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ibuprofen And Pseudoephedrine Hydrochloride, and what generic alternatives are available?
Ibuprofen And Pseudoephedrine Hydrochloride is a drug marketed by Aurobindo Pharma, Perrigo, Aurobindo Pharma Ltd, Contract Pharmacal, and Dr Reddys Labs Ltd. and is included in five NDAs.
The generic ingredient in IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE is ibuprofen; pseudoephedrine hydrochloride. There are sixty-four drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ibuprofen; pseudoephedrine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ibuprofen And Pseudoephedrine Hydrochloride
A generic version of IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE was approved as ibuprofen; pseudoephedrine hydrochloride by DR REDDYS LABS LTD on August 14th, 2006.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE?
- What are the global sales for IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE?
- What is Average Wholesale Price for IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE?
Summary for IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 2 |
| Clinical Trials: | 6 |
| Patent Applications: | 2 |
| DailyMed Link: | IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Pharma Medica Research, Inc. | Phase 1 |
| Institut für Pharmakologie und Präventive Medizin | Phase 1 |
| Boehringer Ingelheim | Phase 1 |
See all IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE clinical trials
Pharmacology for IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE
| Drug Class | Nonsteroidal Anti-inflammatory Drug alpha-Adrenergic Agonist |
| Mechanism of Action | Adrenergic alpha-Agonists Cyclooxygenase Inhibitors |
US Patents and Regulatory Information for IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE | ibuprofen; pseudoephedrine hydrochloride | CAPSULE;ORAL | 209235-001 | Dec 1, 2017 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Contract Pharmacal | IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE | ibuprofen; pseudoephedrine hydrochloride | TABLET;ORAL | 075588-001 | Apr 8, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Perrigo | IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE | ibuprofen; pseudoephedrine hydrochloride | SUSPENSION;ORAL | 076478-001 | Nov 5, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
